Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-137715
Filing Date
2016-08-18
Accepted
2016-08-18 10:29:59
Documents
2
Period of Report
2016-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2661
2 POA DOCUMENT poa.txt EX-24.3_671768 4254
  Complete submission text file 0001209191-16-137715.txt   8533
Mailing Address C/O SCIELE PHARMA, INC. FIVE CONCOURSE PARKWAY, SUITE 1800 ATLANTA GA 30328
Business Address
Ciaffoni Joseph (Reporting) CIK: 0001443841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36326 | Film No.: 161840201

Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Issuer) CIK: 0001593034 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations